Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencySat, 01 Jun 2024 16:31:08 +0200Wed, 15 May 2024 16:15:00 +0200Kaftrio : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5269_en.pdfKaftrio : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5269_en.pdfWed, 15 May 2024 16:15:00 +0200Human medicineHuman medicines European public assessment report (EPAR): Kaftrio, ivacaftor,tezacaftor,elexacaftor, Date of authorisation: 21/08/2020, Revision: 21, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/kaftrioHuman medicines European public assessment report (EPAR): Kaftrio, ivacaftor,tezacaftor,elexacaftor, Date of authorisation: 21/08/2020, Revision: 21, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/kaftrioWed, 15 May 2024 11:44:00 +0200Human medicine